MSS2026: Bridging Science and Innovation in Bioprocessing and Biopharma
We're excited to unveil the first announcement for MSS2026, taking place from September 14 to 16, 2026, in the picturesque location of Bled. This event is set to redefine the landscape of biotechnology, featuring confirmed speakers, dynamic agenda changes, and unparalleled opportunities for innovation, collaboration, and inspiration.
Visionary Keynotes
| Speaker | Affiliation | Topic |
|---|---|---|
| Jacek Lubelski | NanoCell, Netherlands | tLNP as a novel gene therapy vector to deliver DNA — are we there yet? |
| Christy Franco | VGXI, USA | Commercial-ready plasmid manufacturing: scaling late-stage cell & gene therapy with regulatory confidence |
| Stefano Menegatti | North Carolina State University, USA | Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies |
| Dan Peer | Tel Aviv University, Israel | The RNA revolution: from novel vaccines to therapeutic genome editing |
| Andre Germishuizen | National Bioproducts Institute, South Africa | Commercial scale evaluation of a mixed mode CIMmultus monolithic column in the production of human immunoglobulin products |
| Thomas Muster | BlueSky Immunotherapies, Austria | delNS — an interferon inducing viral vector to tackle head & neck cancer |
This is not the complete list of speakers. More names will be announced soon, so stay tuned for updates!
Engaging Wet Lab Workshops in Ajdovščina
Dive into hands-on sessions designed to spark creativity and foster new ideas.
Unmatched Networking
Meet and connect with industry pioneers and fellow professionals to expand your network.
Special Offers
- Super Early Bird Registration: Secure your spot by January 31, 2026, for special rates.
- Abstract Submission: Submit abstracts for oral (Speaker, Young Researcher) and poster presentations by end of February 2026.